Once a day ocular inserts for sustained delivery of levofloxacin: Design, formulation and evaluation

Main Article Content

Hitesh Gevariya
Abhay Dharamsi
Kundlik Girhepunje
Ranju Pal


Levofloxacin is a fluoroquinolone antibacterial drug effective in the treatment of bacterial conjunctivitis.The objective of the present work was to develop ocular inserts of levofloxacin and evaluate their potential for sustained ocular delivery.
Conventional ophthalmic solution shows the poor bioavailability and therapeutic response due to many pre-corneal constraints. These constrains necessitate the controlled and sustained drug delivery to become a standard one in the modern pharmaceutical era. Matrix-type ocular inserts were prepared by the film-casting technique in Teflon-coated Petri dishes and characterized in vitro by drug release studies using a flow-through apparatus that simulated the eye conditions. Nine formulations were developed, which differed in the ratio of polymers polyethylene oxide (PEO), hydroxypropyl cellulose (HPC) and ethyl cellulose (EC). All the formulations were subjected to evaluation of thickness, weight variation, folding endurance and drug content uniformity and in vitro release study. On the basis of in vitro drug release studies, the formulation with PEO/EC (F9)
was found to be better than the other formulations (release of 101.35% within 24 hrs) and it was selected as an optimized formulation, which was further subjected to in vivo studies and ageing studies. The in vitro result revealed that formulation
F9 followed a perfect zero-order kinetics release (n 5 1.03) and the rest of the formulations released the drug by super case II kinetics (n . 1). It was also observed that increasing the proportion of PEO and HPC to EC increases the rate of release of Levofloxacin. On the basis of in vitro and in vivo correlation stability studies, it can be concluded that this ocular inserts formulation can be a promising once-a-day controlled release formulation.


Download data is not yet available.

Article Details

How to Cite
Gevariya, H., Dharamsi, A., Girhepunje, K., & Pal, R. (2014). Once a day ocular inserts for sustained delivery of levofloxacin: Design, formulation and evaluation. Asian Journal of Pharmaceutics (AJP), 3(4). https://doi.org/10.22377/ajp.v3i4.286


Shoenwald RD. Ocular drug delivery: Pharmacokinetic considerations.

Clinical Pharmacokinetics 1998;18:255-69.

Lee VH. Drugs and pharmaceutical sciences. In: Swarbrick J, editor.

Pre-corneal, corneal and post corneal factors. New York: Marcel Dekker

Inc; 1993. p. 59-81.

Attia MA, Kassem MA, Safwat S. In-vivo performance of dexomethasone

ophthalmic film delivery system in the rabbit eye. International J Pharm


Barath S, Hiremath SR. Ocular delivery systems of pefloxacin mesylate.

Pharmazie 1999;54:55-8.

Available from http://www.medicinescomplete.com [last cited on 2008

Oct dated 12].

Li HY, Li FW, Ping QN. Determination of release rate, miotic activity

and irritation of controlled release pilocarpine ophthalmic f ilm. Nan

Yao Xue 1985;16:21-27.

Kenawy R, Bowlin GL. Release of tetracycline hydrochloride from

electrospun poly (ethylene-co-vinylacetate), Poly (Lactic acid) and a

blend. J Controlled Release 2002;81:57-64.

Vemba T, Gillard J, Roland N. Influence of solvents and plasticizers on

the permeability and the rupture force of ethyl cellulose film coating.

Pharma Acta Helv 1980;55:65-71.

Chowdry KP, Naidu RA. Studies on permeability of ethyl cellulose films

for transdermal use. Eastern Pharmacist 1991;34:119-21.

Hyppola R, Husson I. Evaluation of physical properties of plasticized

ethyl cellulose films cast from ethanol solution. International J Pharm


Yamne S, Takayama K, Nagai T. Effect of fractal dimension on drug

permeation through porous ethyl cellulose films. J Controlled Release


Abhilash AS, Jayaprakash S, Nagarjan M, Dhachinamoorthi D.

Design and evaluation of timolol ocular inserts. Indian J Pharma Sci


Balasubramaniam J, Srinatha A, Pandit JK, Gopalnath. In vitro

microbiological evaluation of polyvinyl alcohol based ocular inserts

of ciprofloxacin hydrochloride. Indian J Pharma Sci 2006;68:626-30.

Langenbucher F. In vitro assessment of dissolution kinetics:

Description and evaluation of a column-type method. J Pharma Sci

;58:1265- 2.

Dandagi PM, Manvi FV, Patil MB, Mastiholimath VS, Rathod R.

Development and evaluation of ocular films of cromolyn sodium. Indian

J Pharm Sci 2004;66:309-12.

Wilhelmus KR. The Draize eye test. Survey of Ophthalmology


Sankar V, Chandrasekaran AK, Durga S, Geetha G. Design and evaluation of diclofenac sodium ophthalmic inserts. The Indian Pharmacist


Saettone MF, Lotta S. Ocular inserts for topical delivery. Adv Drug Del

Rev 1995;16:95-106.